SCHEMBL8205901

SCHEMBL8205901

Nc1ccc(NC(=O)c2cc(O)ccc2Cl)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.57
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
HSD17B10 Q99714 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
GFER P55789 2/20 0.52
ALDH1A1 P00352 3/20 0.50
RAB9A P51151 2/20 0.50
KDM4E B2RXH2 1/20 0.50
NPC1 O15118 1/20 0.50
JAK2 O60674 1/20 0.47
TYK2 P29597 1/20 0.47
CYP1A2 P05177 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
MAPK1 P28482 1/20 0.45
RORC P51449 2/20 0.44
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212669 0.89 MAPT (0.46) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL28582515 0.83 ALDH1A1 (0.67) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL25395048 0.82 MAPT (0.66) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL22089468 0.81 MEN1 (0.60) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL8213832 0.81 HSD17B10 (0.53) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL18147101 0.81 MEN1 (0.52) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL18146154 0.80 CYP1A2 (0.68) MAPTKMT2AMEN1HSD17B10SMN1; SMN2
SCHEMBL8054228 0.79 SMN1; SMN2 (0.67) MAPTKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL8212323 0.78 RORC (0.53) MAPTKMT2AMEN1SMN1; SMN2GFER
SCHEMBL29617476 0.78 KCNMA1 (0.68) MAPTKMT2AMEN1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021088-A2 SALICYLANILIDES ENHANCE ORAL DELIVERY OF THERAPEUTIC PEPTIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNINA (US) 2008-02-21 WO disclosed